Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allogeneic bone marrow transplantation in Japan

S Okamoto1, S Asano, H Shibata

  • 1Department of Hematology/Oncology, University of Tokyo, Japan.

Bone Marrow Transplantation
|June 1, 1994
PubMed
Summary

Allogeneic bone marrow transplantation (BMT) is increasingly used in Japan for various diseases. Research focuses on growth factors and immunosuppressants, with lower graft-versus-host disease incidence noted in Japanese populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gene expression of angiotensin II receptor in blood cells of Cushing's syndrome.

Hypertension (Dallas, Tex. : 1979)·1995
Same author

Attenuation of glycogenolytic action of activin A in intact rat liver.

The American journal of physiology·1995
Same author

[Ictal electroencephalographic recordings of patients with seizure].

Rinsho byori. The Japanese journal of clinical pathology·1995
Same author

Expression of calcium-permeable cation channel CD20 accelerates progression through the G1 phase in Balb/c 3T3 cells.

The Journal of biological chemistry·1995
Same author

[Clinicopathological studies of anti-HCV P1P4 core antibody].

Rinsho byori. The Japanese journal of clinical pathology·1995
Same author

Seroprevalence of hepatitis B and C viruses in eastern Nepal.

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases·1994

Area of Science:

  • Hematology
  • Immunology
  • Transplantation medicine

Background:

  • Allogeneic bone marrow transplantation (BMT) is a growing therapeutic option for diverse diseases.
  • Japanese BMT practices show a lower incidence of acute graft-versus-host disease.
  • This may be linked to reduced histocompatibility antigen disparities in the Japanese population.

Purpose of the Study:

  • To review the current landscape and distinctive features of allogeneic BMT in Japan.
  • To highlight research advancements in BMT within Japan.

Main Methods:

  • Review of current research and clinical practices in allogeneic BMT in Japan.
  • Analysis of factors contributing to outcomes, such as graft-versus-host disease incidence.
  • Examination of the application of novel therapeutic agents.

Related Experiment Videos

Main Results:

  • Allogeneic BMT is increasingly adopted for treating various conditions in Japan.
  • A lower incidence of acute graft-versus-host disease is observed, potentially due to genetic factors.
  • Research has explored recombinant hemopoietic growth factors and new immunosuppressive drugs.

Conclusions:

  • Allogeneic BMT is a significant and evolving treatment modality in Japan.
  • Understanding population-specific factors like histocompatibility may improve BMT outcomes.
  • Ongoing research into growth factors and immunosuppression promises further advancements.